Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014
- PMID: 26529166
- PMCID: PMC4788090
- DOI: 10.1001/jama.2015.10347
Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014
Figures

References
-
- Centers for Disease Control and Prevention. Update to CDC’s sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins are no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012;61:590–594. - PubMed
-
- [accessed January 14, 2015];Gonococcal Isolate Surveillance Project (GISP) Protocol. Available at http://www.cdc.gov/std/gisp/gisp-protocol-oct-2014.pdf.
-
- Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, et al. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011. Lancet Infect Dis. 2013;13:762–768. - PubMed
-
- European Centre for Disease Prevention and Control. [accessed May 8, 2015];Gonococcal antimicrobial susceptibility in Europe —2012. Available at: http://ecdc.europa.eu/en/publications/Publications/gonococcal-antimicrob....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical